Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/
Sign up for our newsletter

Menu

  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships
    • From the Collection

      Changing Child Care

      Illustration of a woman feeding a baby a bottle
      • 1 in 4 parents report being fired for work interruptions due to child care breakdowns

        Chabeli Carrazana · February 2
      • Washington, D.C., offers financial relief to local child care workers

        Orion Rummler · September 20
      • As climate change worsens hurricane season in Louisiana, doulas are ensuring parents can safely feed their babies

        Jessica Kutz · May 5
    • From the Collection

      Next-Gen GOP

      Illustration of a woman riding an elephant
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • A banner year for Republican women

        Amanda Becker · November 11
      • Republican women could double representation in the U.S. House

        Amanda Becker · November 4
    • From the Collection

      On The Rise

      Illustration of three women marching
      • Can Cheri Beasley build a winning coalition in North Carolina?

        Candice Norwood · October 11
      • Los Angeles has never elected a woman mayor. Karen Bass hopes to change that.

        Nadra Nittle · September 8
      • Judge J. Michelle Childs is confirmed to D.C. appeals court

        Candice Norwood · July 20
    • From the Collection

      Pandemic Within a Pandemic

      Illustration of four people marching for Black Lives Matter with coronavirus as the backdrop
      • Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won’t.

        Orion Rummler · November 23
      • Why are more men dying from COVID? It’s a complicated story of nature vs. nurture, researchers say

        Mariel Padilla · September 22
      • Few incarcerated women were released during COVID. The ones who remain have struggled.

        Candice Norwood · August 17
    • From the Collection

      Portraits of a Pandemic

      Illustration of a woman wearing a mask and holding up the coronavirus
      • For family caregivers, COVID is a mental health crisis in the making

        Shefali Luthra · October 8
      • A new database tracks COVID-19’s effects on sex and gender

        Shefali Luthra · September 15
      • Pregnant in a pandemic: The 'perfect storm for a crisis'

        Shefali Luthra · August 25
    • From the Collection

      The 19th Explains

      People walking from many articles to one article where they can get the context they need on an issue.
      • The 19th Explains: What we know about Brittney Griner’s case and what it took to get her home

        Candice Norwood, Katherine Gilyard · December 8
      • The 19th Explains: Why the Respect for Marriage Act doesn’t codify same-sex marriage rights

        Kate Sosin · December 8
      • The 19th Explains: Why baby formula is still hard to find months after the shortage

        Mariel Padilla · December 1
    • From the Collection

      The Electability Myth

      Illustration of three women speaking at podiums
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • Stepping in after tragedy: How political wives became widow lawmakers

        Mariel Padilla · May 24
      • Do term limits help women candidates? New York could be a new testing ground

        Barbara Rodriguez · January 11
    • From the Collection

      The Impact of Aging

      A number of older people walking down a path of information.
      • From ballroom dancing to bloodshed, the older AAPI community grapples with gun control

        Nadra Nittle, Mariel Padilla · January 27
      • 'I'm planning on working until the day I die': Older women voters are worried about the future

        Mariel Padilla · June 3
      • Climate change is forcing care workers to act as first responders

        Jessica Kutz · May 31
    • From the Collection

      Voting Rights

      A series of hands reaching for ballots.
      • Connecticut voters approved early voting. Here’s how their new secretary of state wants to make it happen.

        Barbara Rodriguez · February 13
      • Women lawmakers in Minnesota are in the vanguard of the democracy movement

        Barbara Rodriguez · February 3
      • Election workers believe in our system — and want everyone else to, too

        Barbara Rodriguez, Jennifer Gerson · November 8

    View all collections

  • Explore by Topic

    • 19th Polling
    • Abortion
    • Business & Economy
    • Caregiving
    • Coronavirus
    • Education
    • Election 2020
    • Election 2022
    • Election 2024
    • Environment & Climate
    • Health
    • Immigration
    • Inside The 19th
    • Justice
    • LGBTQ+
    • Military
    • Politics
    • Press Release
    • Race
    • Sports
    • Technology

    View All Topics

Home
  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th Represents Summit

Don’t miss our biggest event of 2023!

Register Today

Become a member

The 19th thanks our sponsors. Become one.

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the Johnson & Johnson logo.
(Photo by JUSTIN TALLIS/AFP via Getty Images)

Coronavirus

CDC advisers want more information before making decision on Johnson & Johnson vaccine

Six women who received the vaccine developed rare blood clots and low platelet levels. It's not clear if there was a causal effect.

Shefali Luthra

Health Reporter

Shefali Luthra portrait

Published

2021-04-14 16:33
4:33
April 14, 2021
pm

Share

  • Twitter
  • Facebook
  • Email

A top government panel delayed making a decision on how to address the Johnson & Johnson COVID-19 vaccine, following concerns about blood clots and low blood platelet levels in at least six women who received the vaccine. 

The move came after an emergency meeting Wednesday of the Advisory Committee on Immunization Practices, which advises the Centers for Disease Control and Prevention. The committee met after the U.S. government advised temporarily halting use of the Johnson & Johnson shot Tuesday. 

It means that the temporary pause will continue, and the committee will reconvene when there is more data collected about the vaccine’s relationship to the blood clots — a process that could take a week to 10 days. 

The 19th thanks our sponsors. Become one.

The United States has administered 6.8 million Johnson & Johnson shots — a fraction of the total 190 million COVID vaccines used so far. The other two vaccines, developed by Pfizer and Moderna, have not raised similar concerns.

The six cases reported so far all emerged in women younger than 48, one of whom has died, and several others are still in hospital care. One more potential case is being investigated, per data presented at the Wednesday meeting. Two similar blood clot cases emerged while the Johnson & Johnson drug was still in clinical trials — one in a 25-year-old man, one in a 24-year-old woman.

Still, it’s not fully clear what is behind the blood clot-low platelet combination. In general, women are at higher risk for this particular kind of blood clot, known as cerebral venous sinus thrombosis (CVST). Adults older than 65 are at lower risk. But CVST is already rare, and it is even less common to see it in conjunction with low blood platelets. 

Typically, pregnancy or being postpartum can elevate the risk for CVST. So can oral contraception. But none of the six reported cases involved someone who was pregnant or postpartum. Only one person was on estrogen or progesterone, according to government data.

Though only 6 out of 6.8 million Johnson & Johnson doses have so far seen the CVST concern emerge, it’s not clear if there is in fact a causal relationship. 

More cases may also be reported, experts note, now that doctors have been alerted to keep an eye out for the symptoms, so it’s difficult to properly assess how common these symptoms are in people who have received the vaccine compared to the general population.

The committee was presented with several options in Wednesday’s meeting: delay making a decision, recommend the Johnson & Johnson vaccine go back into distribution, extend the pause or recommend the vaccine only for men or only for adults of a certain age, who may be less likely to develop CVST and low blood platelet count. 

But CDC advisers worried that there still isn’t enough information to fully understand which populations are at risk — including whether there is in fact a gender-gap for risk. The United States has also already administered at least one shot to almost 80 percent of all adults older than 65, limiting the potential for senior citizens to receive the Johnson & Johnson shot.

In Europe, experts are weighing whether to recommend a vaccine developed by AstraZeneca, which has had similar concerns, exclusively only to adults older than 60. 

Extending a pause on the vaccine, some committee members argued, would give more time to collect data and make sure health care providers are appropriately diagnosing and treating people who develop blood clot-related symptoms. CVST and low platelet count require different treatment from other, more common blood clots known as deep vein thrombosis.

Withdrawing the vaccine or delaying its use could have implications for vaccine equity, both domestically and abroad as experts worry that new, more transmissive variants of the virus could lead to a fourth coronavirus surge.

Johnson & Johnson shot is the only one-dose vaccine authorized in the United States, and the only one that does not require freezer storage — both traits that made it potentially more valuable in reaching rural areas and helping vaccinate people who may not be able to visit a medical site multiple times. 

“Any extension of the pause will invariably result in the fact that the most vulnerable individuals in the U.S., who are prime candidates for the J&J vaccine, will remain vulnerable,” said Dr. Nirav Shah, head of the Association of State and Territorial Health Officials, who is not a member of the committee.

In fact, the pause has already complicated some efforts to vaccinate people experiencing homelessness, affected vaccine supply for mobile vaccine clinics and, in some areas, undercut efforts to vaccinate people who are incarcerated.

“We were planning on using this vaccine in Massachusetts for people who were homebound and not able to get a vaccine,” said Dr. Camille Kotton, an associate professor at Harvard Medical School and voting ACIP member. “…it’s a significant loss.”

Still, it’s unlikely to dramatically slow down the nation’s vaccination effort — at least for now.

But manufacturing problems had forced Johnson & Johnson to back away from its April vaccine delivery targets, though White House officials said efforts were underway to bring the company back up to speed. At a Wednesday briefing, White House coronavirus response coordinator Jeffrey Zients said that the Johnson & Johnson pause would not stop the country from meeting its vaccination targets, which includes having enough supply to immunize the entire adult population by the end of May. 

Concerns could be further-reaching in other countries that have not received robust supplies of Pfizer and Moderna vaccines, and that are more likely to end up relying on a combination of the Johnson & Johnson vaccine and the AstraZeneca shot.

Already, the AstraZeneca blood clot concerns — despite the condition’s rarity — have been cited as a source of vaccine skepticism in other countries, especially in Africa. Some experts worry a similar issue could emerge with the Johnson & Johnson shot. 

Share

  • Twitter
  • Facebook
  • Email

The 19th Represents Summit

Don’t miss our biggest event of 2023!

Register Today

Become a member

Up Next

A photo illustration of woman looking out her window and another one looking up toward her.

Coronavirus

Survey: 69 percent of women under age 30 say COVID-19 has harmed their mental health

Women are more likely to have experienced psychological consequences from the public health crisis. The health care system may not be equipped to respond.

Read the Story

The 19th
The 19th is a 501(c)(3) tax-exempt organization. Our stories are free to republish in accordance with these guidelines.

  • Donate
  • Newsletter
  • Events
  • Search
  • Jobs
  • Fellowships
  • Contact Us
  • About Us
  • Community Guidelines
  • Membership
  • Membership FAQ
  • Major Gifts
  • Sponsorship
  • Privacy
  • Twitter
  • Facebook
  • Instagram